HEALTH PROFESSIONS CONCEPT REVIEW
GUIDE 2026 PHARMACOKINETICS AND
PHARMACODYNAMICS BASICS
◉ What was the first documented use of pharmacology?
Answer: In Egypt.
◉ When was the Pure Food and Drug Act passed in the United
States?
Answer: 1906.
◉ What do drug standards rules assure consumers?
Answer: makes patient get what they pay for. That all preparations
called by the same drug name must be of uniform strength, quality,
and purity.
◉ What is the purpose of the 1906 Pure Food and Drug
Administration?
Answer: To establish consumer protection standards for
manufactured food and drugs.
,◉ What two references were established by the 1906 legislation?
Answer: United States Pharmacopeia (USP) and National Formulary.
◉ What did the 1938 Federal Food, Drug, and Cosmetic Act
establish?
Answer: The FDA (Food and Drug Administration) under the
Department of Health and Human Services to enforce the provisions
of the act.
◉ What is the National Drug Directory (NDC)?
Answer: A list of all drugs manufactured for commercial
distribution, identified by a three-part NDC number.
◉ What does the first part of the NDC number identify?
Answer: The manufacturer.
◉ What does the second part of the NDC number identify?
Answer: The drug.
◉ What does the third part of the NDC number identify?
Answer: The package size.
◉ What is the Controlled Substance Act of 1970?
, Answer: It established the DEA to enforce provisions regarding
controlled substances and set tighter controls on specific groups of
drugs.
◉ What are the five schedules of controlled substances based on?
Answer: Their medical value, harmfulness, and potential for abuse
or addiction.
◉ What is an example of a Schedule I controlled substance?
Answer: Heroin, LSD, methamphetamine, ecstasy.
◉ What is required for prescribing Schedule II controlled
substances?
Answer: Written prescriptions only; electronic prescriptions may be
used if they meet DEA standards.
◉ How many times can Schedule III controlled substances be
refilled?
Answer: Up to 5 times.
◉ What does the 1983 Orphan Drug Act provide?
Answer: Financial incentives for pharmaceutical companies to
develop medications for diseases affecting small populations.